Karadeniz Technical University is a public research university in Trabzon, in the Black Sea Region of Turkey. Established in 1955, it is the fourth oldest university in Turkey. Karadeniz Technical University is a state university institution subject to the Law No. 2547 on Higher Education in Turkey.

During the past decade, Karadeniz Technical University conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 11 clinical trials were completed, i.e. on average, 18.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 7 clinical trials were completed. i.e. 19.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karadeniz Technical University" #1 sponsor was "Karadeniz Technical University" with 22 trials, followed by "Janssen Research & Development, LLC" with 13 trials sponsored, "Hoffmann-La Roche" with 12 trials sponsored, "Abbott Nutrition" with 2 trials sponsored and "Janssen Sciences Ireland UC" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karadeniz Technical University" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "CenTrial GmbH" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Karadeniz Technical University" are "Hepatitis B, Chronic" (4 trials), "Crohn's Disease" (3 trials), "Multiple Sclerosis" (3 trials), "Ulcerative Colitis" (3 trials) and "Gastrointestinal Tolerance" (2 trials). Many other conditions were trialed in "Karadeniz Technical University" in a lesser frequency.

Most popular intervention types in "Karadeniz Technical University" are "Drug" (37 trials), "Other" (14 trials), "Biological" (5 trials), "Procedure" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Ocrelizumab" (6 trials), "JNJ-73763989" (4 trials), "Bendamustine" (3 trials) and "Etrasimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Karadeniz Technical University" are 57 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Karadeniz Technical University". undefined are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Karadeniz Technical University, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Karadeniz Technical University, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Karadeniz Technical University has several departments that took part in Clinical trials: "Karadeniz Technical University Medical Faculty" - 6 trials, "Department Of Chest Diseases, School Of medicine, Karadeniz Technical University" - 2 trials, "Karadeniz Technical University Medical Faculty Department of Anesthesiology and Reanimation" - 2 trials